What is Cryobio?
Cryobio operates as a premier provider in the fertility technology space, specializing in the procurement and distribution of high-quality donor sperm. With a legacy spanning over 35 years, the organization has institutionalized rigorous screening protocols, ensuring that all donors adhere to stringent physical, educational, genetic, and medical benchmarks. By maintaining a focus on high-motility sperm vials and expert laboratory supervision, Cryobio serves a diverse clientele, ranging from individual prospective parents to clinical fertility centers. The company distinguishes itself through a commitment to transparent pricing models and a comprehensive, supportive service framework designed to navigate the complexities of the family-building journey.
How much funding has Cryobio raised?
Cryobio has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Cryobio
PPP
Public-Private Partnership
What's next for Cryobio?
With this late-stage financing, Cryobio is positioned to further solidify its infrastructure and expand its reach within the global fertility market. The strategic allocation of these funds will likely focus on enhancing laboratory capabilities, optimizing donor recruitment pipelines, and potentially integrating advanced digital health tools to streamline the client experience. As the demand for reliable, high-standard reproductive solutions continues to rise, Cryobio's ability to leverage this capital will be critical in maintaining its competitive advantage and operational excellence. The company remains focused on scaling its core offerings while upholding the medical integrity that has defined its long-standing reputation in the industry.
See full Cryobio company page
